Transcriptomic Profiling of Carboplatin- and Paclitaxel-Resistant Lung Adenocarcinoma Cells Reveals CSF3 as a Potential Biomarker for the Carboplatin Plus Paclitaxel Doublet Regimens.
对卡铂和紫杉醇耐药肺腺癌细胞的转录组分析表明，CSF3 可作为卡铂加紫杉醇双药方案的潜在生物标志物
期刊:Current Issues in Molecular Biology
影响因子:3
doi:10.3390/cimb46120834
Raungrut Pritsana, Tanyapattrapong Suchanan, Masjon Thipphanet, Maungchanburi Saowanee, Thongsuksai Paramee
